Pandox AB Series B
Pandox AB (publ), a hotel property company, owns, develops, and leases hotel properties. The company operates in two segments, Leases and Own Operations. The Leases segment leases hotels to hotel operators. The Own Operations segment owns hotel properties; and operates hotels. It has operations in Sweden, Denmark, Norway, Finland, Germany, Belgium, the United Kingdom, Ireland, and internationally… Read more
Pandox AB Series B (0R8U) - Net Assets
Latest net assets as of September 2021: Skr24.72 Billion SEK
Based on the latest financial reports, Pandox AB Series B (0R8U) has net assets worth Skr24.72 Billion SEK as of September 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr65.57 Billion) and total liabilities (Skr40.85 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr24.72 Billion |
| % of Total Assets | 37.7% |
| Annual Growth Rate | 12.18% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 13.68 |
Pandox AB Series B - Net Assets Trend (2016–2020)
This chart illustrates how Pandox AB Series B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Pandox AB Series B (2016–2020)
The table below shows the annual net assets of Pandox AB Series B from 2016 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | Skr23.88 Billion | -9.37% |
| 2019-12-31 | Skr26.35 Billion | +23.26% |
| 2018-12-31 | Skr21.38 Billion | +13.44% |
| 2017-12-31 | Skr18.84 Billion | +24.96% |
| 2016-12-31 | Skr15.08 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pandox AB Series B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 43.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr16.61 Billion | 69.55% |
| Common Stock | Skr460.00 Million | 1.93% |
| Other Components | Skr6.81 Billion | 28.52% |
| Total Equity | Skr23.88 Billion | 100.00% |
Pandox AB Series B Competitors by Market Cap
The table below lists competitors of Pandox AB Series B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Leggett & Platt Incorporated
NYSE:LEG
|
$1.35 Billion |
|
Shenzhen Jufei Optoelectronics
SHE:300303
|
$1.35 Billion |
|
Qi An Xin Technology Group Inc
SHG:688561
|
$1.35 Billion |
|
Technogym SpA
LSE:0RG1
|
$1.36 Billion |
|
SNGN Romgaz SA
LSE:SNGR
|
$1.35 Billion |
|
Shandong Xinchao Energy Co Ltd
SHG:600777
|
$1.35 Billion |
|
Zhejiang Shenghua Biok Biology Co Ltd
SHG:600226
|
$1.35 Billion |
|
Infinera Corporation
NASDAQ:INFN
|
$1.35 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pandox AB Series B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 26,350,000,000 to 23,880,000,000, a change of -2,470,000,000 (-9.4%).
- Net loss of 1,399,000,000 reduced equity.
- Other factors decreased equity by 1,071,000,000.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-1.40 Billion | -5.86% |
| Other Changes | Skr-1.07 Billion | -4.48% |
| Total Change | Skr- | -9.37% |
Book Value vs Market Value Analysis
This analysis compares Pandox AB Series B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Pandox AB Series B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -44.02%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 2.71x
- Recent ROE (-5.86%) is below the historical average (9.77%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 14.59% | 55.79% | 0.10x | 2.55x | Skr692.90 Million |
| 2017 | 16.66% | 73.55% | 0.08x | 2.75x | Skr1.26 Billion |
| 2018 | 13.19% | 55.04% | 0.09x | 2.57x | Skr682.20 Million |
| 2019 | 10.27% | 48.73% | 0.08x | 2.50x | Skr71.00 Million |
| 2020 | -5.86% | -44.02% | 0.05x | 2.71x | Skr-3.79 Billion |
Industry Comparison
This section compares Pandox AB Series B's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pandox AB Series B (0R8U) | Skr24.72 Billion | 14.59% | 1.65x | $1.35 Billion |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |